Back
11 October 2024
o2h Ventures Invests in Stratosvir – Advancing Viral Immunotherapy For Late-Stage Cancer
Stratosvir is incredibly excited to welcome o2h Ventures as new investors. We really appreciate Sunil and his team’s enthusiasm for our mission to develop a new generation of immunotherapy treatments to treat late stage cancer patientsurStratosvir is incredibly excited to welcome o2h April April 2024
Stratosvir is incredibly excited to welcome o2h Ventures as new investors. We really appreciate Sunil and his team’s enthusiasm for our mission to develop a new generation of immunotherapy treatments to treat late stage cancer patients.